Atlas Trials

Phase I Study With V-212 Vaccinations in Healthy Adult Volunteers

Clinical trial NCT06975319 · COMPLETED

Trial details

NCT number
NCT06975319
Sponsor
Virometix
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
HealthyImmunisation Against Streptococcus Pneumoniae
Start date
2025-01-29
Primary completion
2025-12-02
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.